New and More Sensitive Prostate Cancer Imaging on the Near Horizon
At the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, promising results were reported from a phase 2/3 clinical trial testing the accuracy of a new prostate cancer imaging...Read More
Why More Men Are Delaying Treatment for Prostate Cancer
Original article issued by Healthline. When Ben Pfeiffer was diagnosed with prostate cancer in April, his urologist noted in the biopsy report that he was leaning toward recommending that Pfeiffer...Read More
Modell’s Sporting Goods Partners With the Prostate Cancer Foundation During Men’s Health Month to Raise Funds for Prostate Cancer Research
NEW YORK, NY, June 5, 2018 – June is Men’s Health Month and to heighten awareness about a men’s health issue – prostate cancer – Modell’s Sporting Goods will be...Read More
Prostate Cancer Foundation’s Statement on Late-Breaking ASCO Presentation Regarding Racial Differences in Prostate Cancer and Call for Greater Diversity in Clinical Trial Participation
JUNE 1, 2018 - Each year three million men in the U.S. battle prostate cancer and on average one in nine men will be diagnosed in their lifetime. However, there...Read More
The Prostate Cancer Foundation and Major League Baseball are Back In Full Swing To Defeat Prostate Cancer with the 23rd Annual Home Run Challenge
LOS ANGELES, Calif., May 31, 2018 – From June 1 to 17 (Father’s Day), the Prostate Cancer Foundation (PCF) and Major League Baseball (MLB) will team up for the 23rd...Read More
VA Healthcare System Successfully Reduces ‘Rush to Treatment’ Rates for Low-Risk Prostate Cancer, Study Shows
May 15, 2018 - Record numbers of American veterans diagnosed with nonaggressive prostate cancer are heeding the advice of international medical experts and opting out of immediate surgery or radiation...Read More
Prostate Cancer Foundation Statement on U.S. Preventive Services Task Force Updated Prostate Screening Guidelines
Yesterday, the USPSTF updated its 2012 position on prostate cancer screening recommending that clinicians should selectively offer or provide periodic prostate-specific antigen (PSA)–based screening for prostate cancer for men between...Read More
Clinical trial finds strong promise for new treatment that targets radiation directly to prostate cancer
May 8, 2018 A study published today in Lancet Oncology reported highly promising results from a phase 2 clinical trial testing a new treatment, 177Lu-PSMA-617, which targets radiation directly to prostate...Read More
PCF-funded investigators report progress on a promising new treatment for a highly lethal form of prostate cancer
Prostate cancer cells depend on androgens to grow and thrive. Because of this dependency, hormone therapy – the blockade of androgens and the androgen receptor (AR) – has been the...Read More
2018 AACR-Prostate Cancer Foundation Scholar-in-Training Award Recipients
Mark P. Labrecque, PhD University of Washington, Seattle, WA Abstract # 1092 Defining the molecular phenotypes of metastatic castration-resistant prostate cancer sensitive to FGF pathway inhibition M. P. Labrecque1, L....Read More